Aya Mohamed | MSc, MD 🎗· @Dr_Oncologista · X·· 2 天前评分70
正文 · 原文
DESTINY-Breast09: #ESMO26
T-DXd + pertuzumab showed encouraging systemic and intracranial activity in 1L HER2+ mBC with baseline brain metastases, with CNS-PFS HR 0.26 vs THP.
@OncoAlert #BreastCancer #bcsm #ESMOAmbassadors #ESMOcommunity @myESMO
115 浏览 · 8 赞 · 2 转发 · 1 回复
帖内回复
- Aya Mohamed | MSc, MD 🎗@Dr_Oncologista
@OncoAlert @myESMO A compelling signal, but how will these data shape first-line treatment decisions?
来源：Aya Mohamed | MSc, MD 🎗 · x.com